Disability Examination Worksheets
Liver, Gall Bladder, and Pancreas
Name: |
SSN: |
Date of Exam: |
C-number: |
Place of Exam: |
A. Review of Medical Records: This may be of
particular importance when hepatitis C or chronic liver disease is claimed as
related to service. B. Medical History (Subjective Complaints):
- For Gall Bladder Disease (Including Gall bladder removal):
Episodes of colic or other abdominal pain, distention, nausea, and / or
vomiting. Include a statement on frequency of attacks (number within past
year). Provide statement as to what x-ray (or other) evidence supports
diagnosis of chronic cholecystitis. Include current treatment - type
(medication, diet, etc.), duration, response, side effects. For Gall Bladder
injury, refer to Stomach, Duodenum and Peritoneal Adhesions worksheet.
- For Pancreatic conditions: Does veteran have steatorrhea,
malabsorption, or malnutrition? Comment on whether veteran has attacks of
abdominal pain. Include frequency of attacks (per year). Comment on whether
veteran has diarrhea, weight loss. Is there evidence of continuing pancreatic
insufficiency between acute attacks? Provide evidence (lab or other clinical
studies) that abdominal pain is a consequence of pancreatic disease. Has
veteran had pancreatic surgery? If so, describe. Include current treatment -
type (medication, diet, enzymes, etc.), duration, response, side effects.
- For Chronic Liver disease (including hepatitis B, chronic
active hepatitis, autoimmune hepatitis, hemochromatosis, drug-induced
hepatitis, etc., but excluding bile duct disorders and Hepatitis C): (a)
Does veteran have "incapacitating episodes" (defined as periods of acute
signs and symptoms with symptoms such as fatigue, malaise, nausea, vomiting,
anorexia, arthralgia, and right upper quadrant pain with symptoms severe enough
to require bed rest and treatment by a physician)? If so, provide frequency of
episodes and total duration of episodes over the past 12-month period. Please
include comment on whether this is veteran reported, and / or documented in the
available records. (b) Include current treatment - type (medication,
diet, enzymes, etc.), duration, response, side effects. (c) Comment on
presence and severity (e.g. near-constant, debilitating, daily or
intermittent), as appropriate, of fatigue, malaise, anorexia and weight loss,
right upper quadrant pain and hepatomegaly. (d) Include a history of
risk factors for the liver condition which the veteran is claiming service
connection. For instance (as appropriate) is there a history of occupational
blood exposure? IV drug use? Taking medications that are associated with liver
disease? Include a history of alcohol use / abuse, past and present. Note
presence or absence of extrahepatic manifestations of veteran's liver disease
(e.g. vasculitis, kidney disease, arthritis.) Refer to additional worksheets as
necessary. See and address 4. Cirrhosis of the liver when cirrhosis is a
sequelae. See and address 7 (below) where veteran is status post liver
transplant.
- For Cirrhosis of the Liver, primary biliary cirrhosis, cirrhotic
phase of sclerosing cholangitis, or as a sequelae of hepatitis from any cause:
(a)Fully describe the following, indicating, as appropriate, the number of
episodes, periods of remission, or whether the condition is refractory to
treatment: (i) ascites, (ii) hepatic encephalopathy, (iii)
hemorrhage from varicies (include comment on episodes of hemetemesis and/or
melana, (iv) portal gastropathy (v) portal hypertension,
(vi) jaundice. (b) comment on: (i) current treatment (s)
(medications, diet, response, side effects, duration) (ii) Discuss
presence, frequency (e.g., daily, intermittent, etc.) and severity of each of
the following: weakness, anorexia, malaise, abdominal pain, weight loss
(include amount and time frame), weight gain, and weakness. Note presence or
absence of extrahepatic manifestations of veteran's liver disease (e.g.
vasculitis, kidney disease, arthritis.) Refer to additional worksheets as
necessary. See and address 3 (above) where cirrhosis is a sequaele of
Chronic Liver disease (including hepatitis B, chronic active hepatitis,
autoimmune hepatitis, hemochromatosis, drug-induced hepatitis, etc., but
excluding bile duct disorders and Hepatitis C). See and address 7 (below) where
veteran is status post liver transplant.
- For Hepatitis C: (a) Does veteran have "incapacitating
episodes" (defined as periods of acute signs and symptoms with symptoms such as
fatigue, malaise, nausea, vomiting, anorexia, arthralgia, and right upper
quadrant pain with symptoms severe enough to require bed rest and treatment by
a physician)? If so, provide frequency of episodes and total duration of
episodes over the past 12-month period. Please include comment on whether this
is veteran reported, and/ or documented in the available records. (b)
comment on: (i) current treatment (s) (medications, diet, response, side
effects, duration) (ii) Discuss presence, frequency (e.g., daily,
intermittent, etc.) and severity of each of the following: weakness, anorexia,
malaise, abdominal pain, weight loss (include amount and time frame), weight
gain, and weakness. (c) Include a history of risk factors for the liver
condition for which the veteran is claiming service connection. For instance
(as appropriate) is there a history of occupational blood exposure? IV drug
use? See established risk factors for Hepatitis C, below. Note presence or
absence of extrahepatic manifestations of veteran's liver disease (e.g.
vasculitis, kidney disease, arthritis.) Refer to additional worksheets as
necessary. See and address 7 (below) where veteran is status post liver
transplant.
- For Liver Malignancy: Address presence or absence of
symptomatolgy, etc., as outlined in both: 3. (For Chronic Liver disease
(including hepatitis B, chronic active hepatitis, autoimmune hepatitis,
hemochromatosis, drug-induced hepatitis, etc., but excluding bile duct
disorders and Hepatitis C) and 4. (For Cirrhosis of the Liver, primary
biliary cirrhosis, cirrhotic phase of sclerosing cholangitis, or as a sequelae
of hepatitis from any cause) above.
- For Liver Transplant: Provide date of transplant. Describe
current treatment (s) (medications, diet, response, side effects, duration).
Please refer to additional AMIE worksheets to address conditions veteran has as
a consequence of the transplant, treatment for the transplant, and as a
consequence of any underlying disease that prompted the transplant in the first
place (e.g. extrahepatic complications / manifestations of hepatitis C).
- Effects of the condition on occupational functioning and daily activities.
C. Physical Examination (Objective Findings):
Address each of the following as appropriate, and fully describe
current findings:
1. Abdominal Exam
- Describe any areas of tenderness and/or organomegaly, including
liver size and whether it is tender to palpation.
- Presence or absence of ascites
- Evidence of Portal Hypertension (e.g. superficial abdominal
veins, splenomegaly, abdominal pain)
2. General exam
- Describe all other signs of liver disease (e.g. jaundice, palmar
erythema, spider angiomata).
- Evidence of Malnutrition (e.g. muscle wasting)
D. Diagnostic and Clinical Tests:
- For esophageal varices, X-ray, endoscopy, etc.
- For gall bladder disease, X-ray or other objective
confirmation.
- For liver disease:
- serologic tests for hepatitis as appropriate (e.g. HbsAg,
anti-HCV, anti-HBc, ferritin, alpha-fetoprotein); liver imaging as appropriate,
(e.g. ultrasound or abdominal CT scan), biopsy report (when available).
- Viral hepatitis (including Hepatitis C): Name the
specific type (A, B, C, or other). For hepatitis B and / or hepatitis C,
provide an opinion as to which risk factor is the most likely cause, and
whether these risk factors were present during the veteran's time in the
military. Please support your opinion by discussing all risk factors in the
individual and your rationale for your opinion. If you cannot determine which
risk factor is the likely cause, state that there is no risk factor that is
more likely than another to be the cause, and explain.
- Hepatitis C: Please note that Hepatitis C generally
does not produce clinically evident hepatitis at the time of infection. Please
provide results of serologic (anti-HCV antibody) and viral (HCV RNA) testing
for hepatitis C. The anti-HCV assay confirms exposure to hepatitis C but does
not differentiate between chronic, acute, or resolved infection. False positive
and false negative results occur, but rarely. A positive qualitative or
quantitative HCV RNA assay indicates current hepatitis C infection.
A negative qualitative HCV RNA assay indicates that the individual does
not have active, chronic hepatitis C. The recombinant immunoblot assay
(RIBA) is a confirmatory serologic test that establishes the diagnosis of past
(resolved) infection if the anti-HCV is positive but the HCV RNA assay is
negative.
The following are established risk factors for acquisition
of hepatitis C infection:
- Blood transfusion before 1992
- Past or present intravenous drug use
- Blood exposure of skin or mucous membranes including accidental
needle punctures
- Sexual transmission (though most studies have failed to identify
sexual transmission of this agent). Sexual transmission appears to be confined
to such subgroups as persons with multiple sexual partners and sexually
transmitted diseases.
- History of hemodialysis
- Tattoo or repeated body piercing
- History of intranasal cocaine use
See Harrison's Principles of Internal Medicine, 15th edition,
The McGraw Hill Companies, Inc., page 1709, 1729-1730.
Please consider the veteran's potential for skin and mucous membrane
exposure to blood, especially where the veteran was a military corpsman, a
medical worker, or a combat veteran.
d. Cirrhosis, chronic hepatitis, liver malignancy, or
other chronic liver disease: State the most likely etiology. Address the
relationship of the disease to active service, including any hepatitis that
occurred in service.
- Include results of all diagnostic and clinical tests conducted in
the examination report.
E. Diagnosis:
Signature: |
|
Date: |
|
|
|
|
Reviewed/Updated Date: December 15, 2008 |
|